Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 12, 2023

SELL
$35.53 - $43.38 $283,778 - $346,476
-7,987 Reduced 47.12%
8,963 $365,000
Q4 2022

Feb 07, 2023

BUY
$38.19 - $57.45 $647,320 - $973,777
16,950 New
16,950 $654,000
Q2 2019

Jul 17, 2019

BUY
$36.57 - $47.97 $8,667 - $11,368
237 Added 2.68%
9,078 $395,000
Q1 2019

Oct 17, 2019

BUY
$36.47 - $42.17 $322,431 - $372,824
8,841 New
8,841 $336,000

Others Institutions Holding PCRX

About Pacira BioSciences, Inc.


  • Ticker PCRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 45,824,200
  • Market Cap $892M
  • Description
  • Pacira BioSciences, Inc. provides non-opioid pain management and regenerative health solutions for healthcare practitioners and their patients in the United States. The company offers EXPAREL, a bupivacaine liposome injectable suspension; ZILRETTA, a triamcinolone acetonide extended-release injectable suspension; and iovera system, a non-opioid ...
More about PCRX
Track This Portfolio

Track Fox Run Management, L.L.C. Portfolio

Follow Fox Run Management, L.L.C. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fox Run Management, L.L.C., based on Form 13F filings with the SEC.

News

Stay updated on Fox Run Management, L.L.C. with notifications on news.